MARKET

ACCD

ACCD

Accolade, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

49.35
+1.10
+2.28%
After Hours: 49.50 +0.15 +0.30% 16:30 12/04 EST
OPEN
48.26
PREV CLOSE
48.25
HIGH
50.06
LOW
47.57
VOLUME
315.26K
TURNOVER
--
52 WEEK HIGH
55.54
52 WEEK LOW
28.68
MARKET CAP
2.32B
P/E (TTM)
-17.9090
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Michelle Snyder, Digital Health Veteran, Joins McKesson Ventures
McKesson Ventures, the venture capital arm of McKesson Corporation, announces the expansion of its leadership team, welcoming Michelle Snyder as its newest investment partner. Snyder brings more than 25 years of healthcare experience to the team and will support investments in healthcare technology and services companies. Snyder's hire expands the number of female partners at McKesson Ventures underscoring a commitment to diversifying its leadership team.
BusinessWire · 4d ago
Accolade to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the Piper Sandler 32 Annual Virtual Healthcare Conference, including a fireside chat presentation, on Tuesday, December 1, 2020. An audio replay and related presentation materials will be available at ir.accolade.com.
GlobeNewswire · 11/20 13:33
Accolade to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
SEATTLE, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, including a fireside chat presentation, on Tuesday, December 1, 2020. An audio replay and related presentation materials will be available at ir.accolade.com. About Accolade, Inc.Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Using a blend of cloud-based technologies, specialized support from Accolade Health Assistants® and Clinicians, and integrated data and programs across mobile, online and phone, Accolade navigates people through the healthcare system with trust, empathy and ease. Employers offer Accolade to employees and their families as the single place to turn for all health, healthcare, and benefits questions or concerns, increasing their engagement in benefits and connecting them to high-quality providers and care. By empowering members to make better decisions about their health, Accolade can support members in lowering the cost and complexity of healthcare while achieving consumer satisfaction ratings over 90 percent and an NPS of 60.Investor Contact:Todd Friedman, Investor Relations, 484-532-5200, IR@accolade.comAsher Dewhurst, Investor Relations, 443-213-0503, accolade@westwicke.comMedia Contact:Megan Torres, Public Relations, 206-679-9630, Megan.Torres@accolade.comSource: Accolade
GlobeNewswire · 11/20 13:00
Accolade to Participate in the 29th Annual Credit Suisse Healthcare Conference
Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the virtual 29th Annual Credit Suisse Healthcare Conference, including a fireside chat presentation on Wednesday, November 11, 2020 at 10:15 a.m. E.T. An audio webcast and related presentation materials will be available at ir.accolade.com.
GlobeNewswire · 10/28 12:30
Accolade Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Accolade, Inc. (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced the closing of its public offering of 5,750,000 shares of its common stock, inclusive of the full exercise by the underwriters of their option to purchase 750,000 shares of common stock, at a price to the public of $38.50 per share. The aggregate gross proceeds to Accolade from the offering, before deducting the underwriting discount and other offering expenses, were approximately $221.4 million.
GlobeNewswire · 10/26 20:05
Accolade Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
SEATTLE, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced the closing of its public offering of 5,750,000 shares of its common stock, inclusive of the full exercise by the underwriters of their option to purchase 750,000 shares of common stock, at a price to the public of $38.50 per share. The aggregate gross proceeds to Accolade from the offering, before deducting the underwriting discount and other offering expenses, were approximately $221.4 million. Goldman Sachs & Co. LLC, Morgan Stanley and BofA Securities acted as joint book-running managers for the offering. Piper Sandler, Credit Suisse and William Blair acted as book-running managers. Baird, SVB Leerink, Canaccord Genuity and Academy Securities acted as co-managers.The offering was made only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained from: Goldman Sachs & Co. LLC,  Attn: Prospectus Department, 200 West Street, New York, New York 10282, or by email at prospectus-ny@ny.email.gs.com; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014 or by email at prospectus@morganstanley.com; or BofA Securities, Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, North Carolina 28255-0001, or by email at dg.prospectus_requests@bofa.com.Registration statements relating to these securities have been filed with, and declared effective by, the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.About Accolade, Inc.Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Using a blend of cloud-based technologies, specialized support from Accolade Health Assistants® and Clinicians, and integrated data and programs across mobile, online and phone, Accolade navigates people through the healthcare system with trust, empathy and ease. Employers offer Accolade to employees and their families as the single place to turn for all health, healthcare, and benefits questions or concerns, increasing their engagement in benefits and connecting them to high-quality providers and care. By empowering members to make better decisions about their health, Accolade can support members in lowering the cost and complexity of healthcare while achieving consumer satisfaction ratings over 90 percent and an NPS of 60.Contact Asher Dewhurst Investor Relations 443-213-0500 Accolade@westwicke.comMegan Torres Public Relations 206-679-9630 Megan.Torres@accolade.comTodd Friedman Investor Relations 484-532-5200 Todd.Friedman@accolade.com
GlobeNewswire · 10/26 20:05
Accolade prices equity offering
Accolade (ACCD) prices its underwritten public offering of 5M common shares at $38.50 per share.Underwriters have an option to purchase up to 750,000 additional common shares. Closing date is October
Seekingalpha · 10/22 04:05
Accolade Announces Pricing of Public Offering of Common Stock
Accolade, Inc. ("Accolade"), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $38.50 per share. The offering is expected to close on October 26, 2020, subject to customary closing conditions. In addition, Accolade has granted the underwriters a 30-day option to purchase up to 750,000 additional shares of its common stock at the public offering price, less the underwriting discount.
GlobeNewswire · 10/22 03:57
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ACCD. Analyze the recent business situations of Accolade, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ACCD stock price target is 48.00 with a high estimate of 55.00 and a low estimate of 42.00.
EPS
Institutional Holdings
Institutions: 79
Institutional Holdings: 17.11M
% Owned: 36.41%
Shares Outstanding: 47.00M
TypeInstitutionsShares
Increased
0
0
New
79
17.11M
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+4.59%
Healthcare Providers & Services
+2.45%
Key Executives
Chairman/Director
J. Michael Cline
President
Robert Cavanaugh
Chief Executive Officer/Director
Rajeev Singh
Chief Financial Officer
Stephen Barnes
Executive Vice President/General Counsel
Richard Eskew
Executive Vice President/General Manager
Todd Clardy
Executive Vice President/General Manager
Matt Eurey
Executive Vice President
Beverly Gibson
Executive Vice President
Phong Nguyen
Executive Vice President
Britt Provost
Executive Vice President
David Wyatt
Senior Vice President/General Manager
Mike McGee
Senior Vice President
Sarah Martino
Senior Vice President
Bill Morrison
Chief Technology Officer
Harish Naidu
Other
Tina Gilbert
Other
Michael Hilton
Other
Shantanu Nundy
Other
Carolyn Young
Independent Director
William Frist
Independent Director
Jeffrey Jordan
Independent Director
Peter Klein
Independent Director
Dawn Lepore
Independent Director
James Madden
Independent Director
Thomas Neff
Independent Director
Patricia Wadors
Independent Director
Michael Yang
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ACCD
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Health Assistants and clinicians (including nurses, physician medical directors, and behavioral health specialists). It leverages its integrated capabilities, connectivity with providers and the broader healthcare ecosystem, and longitudinal data to engage across the entire member population. The Company’s offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits and Accolade Boost.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Accolade Inc stock information, including NASDAQ:ACCD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACCD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACCD stock methods without spending real money on the virtual paper trading platform.